Trends in anti-infective treatment of burn patients: a 3-year retrospective review.
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001207:Asepsis / Q000379:methods; D002056:Burns / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy; D012189:Retrospective Studies; D012837:Silver Sulfadiazine / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D014946:Wound Infection / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D012837:Silver Sulfadiazine